Answers are grounded in this paper and cite their sources.
Dapsone is a component of multi-drug therapy (MDT) for the treatment of all types of leprosy. It is known that dapsone hypersensitivity syndrome (DHS) complicates the treatment in a proportion of patients. We performed a retrospective study of patients commenced on MDT between 1990 and 2006; 2% developed DHS and 0.25% died due to DHS.
No takes yet. Share an insight, caveat, or question.
Pandey et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: